PDM: MNT and Glycemic Outcomes (2022-23)

Author and Year:
Barengo N, Acosta T, Arrieta A, et al. 2019
PubMed ID:
Article Title:
Early Lifestyle Interventions in People with Impaired Glucose Tolerance in Northern Colombia: The DEMOJUAN Project.
Barengo N, Acosta T, Arrieta A, Ricaurte C, Smits D, Florez K, Tuomilehto J
International Journal of Environmental Research and Public Jealth
Year of publication:
Page numbers:
Study Design:
Randomized Controlled Trial
Risk of Bias Assessment Rating:
Low risk
Inclusion Criteria:
Participants 34-69 years of age with a 2-hour post-challenge glucose level of 140-200 mg/dL (IGT) or a fasting plasma glucose level between 100 and 126 mg/dL (impaired fasting glucose) were included in the study. In addition to the initially defined inclusion criteria when registering the trial, the trial also accepted participants with isolated impaired fasting glucose (n = 109) into the study.
Exclusion Criteria:
People with pharmacologically treated diabetes and hypertriglyceridemia while undergoing drug treatment, a history of life-limiting diseases or events, and an unwillingness to sign the informed consent were excluded from the study.
Research Purpose:
The objective of the demonstration project for type 2 diabetes prevention in the Barranquilla and Juan Mina (DEMOJUAN) study was to investigate the extent to which it is possible to reach normal glucose metabolism with early lifestyle interventions in people at high risk of type 2 diabetes (prediabetes), compared with those who receive standard usual care.
Blinding efforts:
Not reported.
Study Location:
Juan Mina and Barranquilla, Northern Colombia
Source(s) of Funding:
Please specify names of funders:
BRIDGES Grant from the Global Diabetes Foundation (BRIDGES is an International Diabetes Federation project, is supported by an educational grant from Lilly Diabetes).